253 related articles for article (PubMed ID: 12036831)
1. Bone complications in children with Gaucher disease.
Bembi B; Ciana G; Mengel E; Terk MR; Martini C; Wenstrup RJ
Br J Radiol; 2002; 75 Suppl 1():A37-44. PubMed ID: 12036831
[TBL] [Abstract][Full Text] [Related]
2. Effect of enzyme replacement therapy with imiglucerase on BMD in type 1 Gaucher disease.
Wenstrup RJ; Kacena KA; Kaplan P; Pastores GM; Prakash-Cheng A; Zimran A; Hangartner TN
J Bone Miner Res; 2007 Jan; 22(1):119-26. PubMed ID: 17032149
[TBL] [Abstract][Full Text] [Related]
3. Response of Gaucher bone disease to enzyme replacement therapy.
Poll LW; Maas M; Terk MR; Roca-Espiau M; Bembi B; Ciana G; Weinreb NJ
Br J Radiol; 2002; 75 Suppl 1():A25-36. PubMed ID: 12036830
[TBL] [Abstract][Full Text] [Related]
4. The effect of enzyme replacement therapy on bone crisis and bone pain in patients with type 1 Gaucher disease.
Charrow J; Dulisse B; Grabowski GA; Weinreb NJ
Clin Genet; 2007 Mar; 71(3):205-11. PubMed ID: 17309642
[TBL] [Abstract][Full Text] [Related]
5. [A retrospective study on enzyme replacement therapy in patients with Gaucher disease].
Duan YL; Zhang YH; Zang Y; Shi HP; Zhang WM; Hu YM
Zhonghua Er Ke Za Zhi; 2006 Sep; 44(9):653-6. PubMed ID: 17217655
[TBL] [Abstract][Full Text] [Related]
6. Clinical consequences of interrupting enzyme replacement therapy in children with type 1 Gaucher disease.
Drelichman G; Ponce E; Basack N; Freigeiro D; Aversa L; Graciela E; Kohan R
J Pediatr; 2007 Aug; 151(2):197-201. PubMed ID: 17643778
[TBL] [Abstract][Full Text] [Related]
7. Effect of miglustat on bone disease in adults with type 1 Gaucher disease: a pooled analysis of three multinational, open-label studies.
Pastores GM; Elstein D; Hrebícek M; Zimran A
Clin Ther; 2007 Aug; 29(8):1645-54. PubMed ID: 17919546
[TBL] [Abstract][Full Text] [Related]
8. Enzyme replacement therapy and bony changes in Egyptian paediatric Gaucher disease patients.
El-Beshlawy A; Ragab L; Youssry I; Yakout K; El-Kiki H; Eid K; Mansour IM; Abd El-Hamid S; Yang M; Mistry PK
J Inherit Metab Dis; 2006 Feb; 29(1):92-8. PubMed ID: 16601874
[TBL] [Abstract][Full Text] [Related]
9. Bone density changes with enzyme therapy for Gaucher disease.
Lebel E; Dweck A; Foldes AJ; Golowa Y; Itzchaki M; Zimran A; Elstein D
J Bone Miner Metab; 2004; 22(6):597-601. PubMed ID: 15490271
[TBL] [Abstract][Full Text] [Related]
10. Imiglucerase low-dose therapy for paediatric Gaucher disease--a long-term cohort study.
Heitner R; Arndt S; Levin JB
S Afr Med J; 2004 Aug; 94(8):647-51. PubMed ID: 15352589
[TBL] [Abstract][Full Text] [Related]
11. Osteopenia in Gaucher disease develops early in life: response to imiglucerase enzyme therapy in children, adolescents and adults.
Mistry PK; Weinreb NJ; Kaplan P; Cole JA; Gwosdow AR; Hangartner T
Blood Cells Mol Dis; 2011 Jan; 46(1):66-72. PubMed ID: 21112800
[TBL] [Abstract][Full Text] [Related]
12. [Osteoarticular manifestations of Gaucher disease in adults: pathophysiology and treatment].
Javier RM; Hachulla E
Presse Med; 2007 Dec; 36(12 Pt 3):1971-84. PubMed ID: 17498916
[TBL] [Abstract][Full Text] [Related]
13. Gaucher disease and bone: laboratory and skeletal mineral density variations during a long period of enzyme replacement therapy.
Ciana G; Addobbati R; Tamaro G; Leopaldi A; Nevyjel M; Ronfani L; Vidoni L; Pittis MG; Bembi B
J Inherit Metab Dis; 2005; 28(5):723-32. PubMed ID: 16151904
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of the densitometric method of hand bone radiograms and assessment of early changes of bone structure in the children with Gaucher s disease on enzyme replacement therapy (ERT)].
Lysoń-Wojciechowska G; Skawiński W; Tylki-Szymańska A
Pediatr Endocrinol Diabetes Metab; 2007; 13(3):159-64. PubMed ID: 17880827
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic approaches to bone pathology in Gaucher disease: past, present and future.
Goker-Alpan O
Mol Genet Metab; 2011 Dec; 104(4):438-47. PubMed ID: 21889384
[TBL] [Abstract][Full Text] [Related]
16. [Gaucher disease: MR evaluation of bone marrow features during treatment with enzyme replacement].
Poll LW; vom Dahl S; Koch JA; Börner D; Willers R; Cohnen M; Jung G; Scherer A; Niederau C; Häussinger D; Mödder U
Rofo; 2001 Oct; 173(10):931-7. PubMed ID: 11588682
[TBL] [Abstract][Full Text] [Related]
17. Enzyme replacement therapy reduces Gaucher cell burden but may accelerate osteopenia in patients with type I disease - a histological study.
Rudzki Z; Okoń K; Machaczka M; Rucińska M; Papla B; Skotnicki AB
Eur J Haematol; 2003 May; 70(5):273-81. PubMed ID: 12694162
[TBL] [Abstract][Full Text] [Related]
18. [Enzyme replacement therapy in Gaucher disease: monitoring visceral and bone changes with MRI].
Tóth J; Szücs FZ; Benkö K; Maródi L
Orv Hetil; 2003 Apr; 144(16):749-55. PubMed ID: 12778625
[TBL] [Abstract][Full Text] [Related]
19. Long-term bone mineral density response to enzyme replacement therapy in a retrospective pediatric cohort of Gaucher patients.
Ciana G; Deroma L; Franzil AM; Dardis A; Bembi B
J Inherit Metab Dis; 2012 Nov; 35(6):1101-6. PubMed ID: 22441841
[TBL] [Abstract][Full Text] [Related]
20. Changes of bone metabolism in seven patients with Gaucher disease treated consecutively with imiglucerase and miglustat.
Mikosch P; Reed M; Baker R; Holloway B; Berger L; Mehta AB; Hughes DA
Calcif Tissue Int; 2008 Jul; 83(1):43-54. PubMed ID: 18553043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
